Diabetic Retinopathy Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Type (Proliferative Diabetic Retinopathy and Diabetic Macular Edema); Treatment (Anti-Vegf Drug, Steroid Implant, Laser Surgeries and Vitrectomy)
Report Code: TIPRE00004185 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Diabetic Retinopathy is a common diabetic eye disease characterized by the damaged blood vessels in retina that results to blurring of vision, vision impairment, and eye hemorrhage.
MARKET DYNAMICS
The Diabetic Retinopathy market is anticipated to grow in the forecast, owing to the factors such as rising prevalence of diabetes, increase in geriatric population, rise in incidence of blindness due to diabetes, awareness facilitating early diagnosis to control the disease, and emergence of combined therapies for treatment of diabetic macular edema. Nevertheless, lack of skilled ophthalmologists and extended time for drugs is expected to restrict the growth of the market during the forecast period.
MARKET SCOPE
The "Global Diabetic Retinopathy Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of Diabetic Retinopathy market with detailed market segmentation by type, treatment and geography. The global Diabetic Retinopathy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Diabetic Retinopathy Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Diabetic Retinopathy market is segmented on the basis of Type and Treatment. Based on Type the market is segmented into Proliferative Diabetic Retinopathy and Diabetic Macular Edema. Based on Treatment the market is segmented into Anti-Vegf Drug, Steroid Implant, Laser Surgeries and Vitrectomy.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Diabetic Retinopathy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Diabetic Retinopathy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Diabetic Retinopathy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Diabetic Retinopathy market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the Diabetic Retinopathy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Diabetic Retinopathy market are anticipated to lucrative growth opportunities in the future with the rising demand for Diabetic Retinopathy market in the global market. Below mentioned is the list of few companies engaged in the Diabetic Retinopathy market.
The report also includes the profiles of Diabetic Retinopathy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Alimera Science
- Allergan Plc
- Ampio Pharmaceuticals
- Bayer AG
- F. Hoffmann-LA Roche
- Novartis International AG
- PFIZER
- Regeneron Pharmaceuticals Inc
- Valeant Pharmaceutical
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetic Retinopathy Market - By Type
1.3.2 Diabetic Retinopathy Market - By Treatment
1.3.3 Diabetic Retinopathy Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. DIABETIC RETINOPATHY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETIC RETINOPATHY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DIABETIC RETINOPATHY MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETIC RETINOPATHY - GLOBAL MARKET OVERVIEW
6.2. DIABETIC RETINOPATHY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETIC RETINOPATHY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PROLIFERATIVE DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
7.3.1. Overview
7.3.2. Proliferative Diabetic Retinopathy and Diabetic Macular Edema Market Forecast and Analysis
8. DIABETIC RETINOPATHY MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
8.1. OVERVIEW
8.2. TREATMENT MARKET FORECASTS AND ANALYSIS
8.3. ANTI-VEGF DRUG
8.3.1. Overview
8.3.2. Anti-Vegf Drug Market Forecast and Analysis
8.4. STEROID IMPLANT
8.4.1. Overview
8.4.2. Steroid Implant Market Forecast and Analysis
8.5. LASER SURGERIES AND VITRECTOMY
8.5.1. Overview
8.5.2. Laser Surgeries and Vitrectomy Market Forecast and Analysis
9. DIABETIC RETINOPATHY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diabetic Retinopathy Market Overview
9.1.2 North America Diabetic Retinopathy Market Forecasts and Analysis
9.1.3 North America Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.1.4 North America Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.1.5 North America Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diabetic Retinopathy Market
9.1.5.1.1 United States Diabetic Retinopathy Market by Type
9.1.5.1.2 United States Diabetic Retinopathy Market by Treatment
9.1.5.2 Canada Diabetic Retinopathy Market
9.1.5.2.1 Canada Diabetic Retinopathy Market by Type
9.1.5.2.2 Canada Diabetic Retinopathy Market by Treatment
9.1.5.3 Mexico Diabetic Retinopathy Market
9.1.5.3.1 Mexico Diabetic Retinopathy Market by Type
9.1.5.3.2 Mexico Diabetic Retinopathy Market by Treatment
9.1.5.4 US Diabetic Retinopathy Market
9.1.5.4.1 US Diabetic Retinopathy Market by Type
9.1.5.4.2 US Diabetic Retinopathy Market by Treatment
9.2. EUROPE
9.2.1 Europe Diabetic Retinopathy Market Overview
9.2.2 Europe Diabetic Retinopathy Market Forecasts and Analysis
9.2.3 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.2.4 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.2.5 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diabetic Retinopathy Market
9.2.5.1.1 Germany Diabetic Retinopathy Market by Type
9.2.5.1.2 Germany Diabetic Retinopathy Market by Treatment
9.2.5.2 France Diabetic Retinopathy Market
9.2.5.2.1 France Diabetic Retinopathy Market by Type
9.2.5.2.2 France Diabetic Retinopathy Market by Treatment
9.2.5.3 Italy Diabetic Retinopathy Market
9.2.5.3.1 Italy Diabetic Retinopathy Market by Type
9.2.5.3.2 Italy Diabetic Retinopathy Market by Treatment
9.2.5.4 Spain Diabetic Retinopathy Market
9.2.5.4.1 Spain Diabetic Retinopathy Market by Type
9.2.5.4.2 Spain Diabetic Retinopathy Market by Treatment
9.2.5.5 United Kingdom Diabetic Retinopathy Market
9.2.5.5.1 United Kingdom Diabetic Retinopathy Market by Type
9.2.5.5.2 United Kingdom Diabetic Retinopathy Market by Treatment
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diabetic Retinopathy Market Overview
9.3.2 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis
9.3.3 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.3.5 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diabetic Retinopathy Market
9.3.5.1.1 Australia Diabetic Retinopathy Market by Type
9.3.5.1.2 Australia Diabetic Retinopathy Market by Treatment
9.3.5.2 China Diabetic Retinopathy Market
9.3.5.2.1 China Diabetic Retinopathy Market by Type
9.3.5.2.2 China Diabetic Retinopathy Market by Treatment
9.3.5.3 India Diabetic Retinopathy Market
9.3.5.3.1 India Diabetic Retinopathy Market by Type
9.3.5.3.2 India Diabetic Retinopathy Market by Treatment
9.3.5.4 Japan Diabetic Retinopathy Market
9.3.5.4.1 Japan Diabetic Retinopathy Market by Type
9.3.5.4.2 Japan Diabetic Retinopathy Market by Treatment
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diabetic Retinopathy Market Overview
9.4.2 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis
9.4.3 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.4.5 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diabetic Retinopathy Market
9.4.5.1.1 South Africa Diabetic Retinopathy Market by Type
9.4.5.1.2 South Africa Diabetic Retinopathy Market by Treatment
9.4.5.2 Saudi Arabia Diabetic Retinopathy Market
9.4.5.2.1 Saudi Arabia Diabetic Retinopathy Market by Type
9.4.5.2.2 Saudi Arabia Diabetic Retinopathy Market by Treatment
9.4.5.3 U.A.E Diabetic Retinopathy Market
9.4.5.3.1 U.A.E Diabetic Retinopathy Market by Type
9.4.5.3.2 U.A.E Diabetic Retinopathy Market by Treatment
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diabetic Retinopathy Market Overview
9.5.2 South and Central America Diabetic Retinopathy Market Forecasts and Analysis
9.5.3 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.5.4 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.5.5 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diabetic Retinopathy Market
9.5.5.1.1 Brazil Diabetic Retinopathy Market by Type
9.5.5.1.2 Brazil Diabetic Retinopathy Market by Treatment
9.5.5.2 Argentina Diabetic Retinopathy Market
9.5.5.2.1 Argentina Diabetic Retinopathy Market by Type
9.5.5.2.2 Argentina Diabetic Retinopathy Market by Treatment
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DIABETIC RETINOPATHY MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALIMERA SCIENCE
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALLERGAN PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AMPIO PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAYER AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS INTERNATIONAL AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. REGENERON PHARMACEUTICALS INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VALEANT PHARMACEUTICAL
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetic Retinopathy Market - By Type
1.3.2 Diabetic Retinopathy Market - By Treatment
1.3.3 Diabetic Retinopathy Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. DIABETIC RETINOPATHY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETIC RETINOPATHY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DIABETIC RETINOPATHY MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETIC RETINOPATHY - GLOBAL MARKET OVERVIEW
6.2. DIABETIC RETINOPATHY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETIC RETINOPATHY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PROLIFERATIVE DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
7.3.1. Overview
7.3.2. Proliferative Diabetic Retinopathy and Diabetic Macular Edema Market Forecast and Analysis
8. DIABETIC RETINOPATHY MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
8.1. OVERVIEW
8.2. TREATMENT MARKET FORECASTS AND ANALYSIS
8.3. ANTI-VEGF DRUG
8.3.1. Overview
8.3.2. Anti-Vegf Drug Market Forecast and Analysis
8.4. STEROID IMPLANT
8.4.1. Overview
8.4.2. Steroid Implant Market Forecast and Analysis
8.5. LASER SURGERIES AND VITRECTOMY
8.5.1. Overview
8.5.2. Laser Surgeries and Vitrectomy Market Forecast and Analysis
9. DIABETIC RETINOPATHY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diabetic Retinopathy Market Overview
9.1.2 North America Diabetic Retinopathy Market Forecasts and Analysis
9.1.3 North America Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.1.4 North America Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.1.5 North America Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diabetic Retinopathy Market
9.1.5.1.1 United States Diabetic Retinopathy Market by Type
9.1.5.1.2 United States Diabetic Retinopathy Market by Treatment
9.1.5.2 Canada Diabetic Retinopathy Market
9.1.5.2.1 Canada Diabetic Retinopathy Market by Type
9.1.5.2.2 Canada Diabetic Retinopathy Market by Treatment
9.1.5.3 Mexico Diabetic Retinopathy Market
9.1.5.3.1 Mexico Diabetic Retinopathy Market by Type
9.1.5.3.2 Mexico Diabetic Retinopathy Market by Treatment
9.1.5.4 US Diabetic Retinopathy Market
9.1.5.4.1 US Diabetic Retinopathy Market by Type
9.1.5.4.2 US Diabetic Retinopathy Market by Treatment
9.2. EUROPE
9.2.1 Europe Diabetic Retinopathy Market Overview
9.2.2 Europe Diabetic Retinopathy Market Forecasts and Analysis
9.2.3 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.2.4 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.2.5 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diabetic Retinopathy Market
9.2.5.1.1 Germany Diabetic Retinopathy Market by Type
9.2.5.1.2 Germany Diabetic Retinopathy Market by Treatment
9.2.5.2 France Diabetic Retinopathy Market
9.2.5.2.1 France Diabetic Retinopathy Market by Type
9.2.5.2.2 France Diabetic Retinopathy Market by Treatment
9.2.5.3 Italy Diabetic Retinopathy Market
9.2.5.3.1 Italy Diabetic Retinopathy Market by Type
9.2.5.3.2 Italy Diabetic Retinopathy Market by Treatment
9.2.5.4 Spain Diabetic Retinopathy Market
9.2.5.4.1 Spain Diabetic Retinopathy Market by Type
9.2.5.4.2 Spain Diabetic Retinopathy Market by Treatment
9.2.5.5 United Kingdom Diabetic Retinopathy Market
9.2.5.5.1 United Kingdom Diabetic Retinopathy Market by Type
9.2.5.5.2 United Kingdom Diabetic Retinopathy Market by Treatment
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diabetic Retinopathy Market Overview
9.3.2 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis
9.3.3 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.3.5 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diabetic Retinopathy Market
9.3.5.1.1 Australia Diabetic Retinopathy Market by Type
9.3.5.1.2 Australia Diabetic Retinopathy Market by Treatment
9.3.5.2 China Diabetic Retinopathy Market
9.3.5.2.1 China Diabetic Retinopathy Market by Type
9.3.5.2.2 China Diabetic Retinopathy Market by Treatment
9.3.5.3 India Diabetic Retinopathy Market
9.3.5.3.1 India Diabetic Retinopathy Market by Type
9.3.5.3.2 India Diabetic Retinopathy Market by Treatment
9.3.5.4 Japan Diabetic Retinopathy Market
9.3.5.4.1 Japan Diabetic Retinopathy Market by Type
9.3.5.4.2 Japan Diabetic Retinopathy Market by Treatment
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diabetic Retinopathy Market Overview
9.4.2 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis
9.4.3 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.4.5 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diabetic Retinopathy Market
9.4.5.1.1 South Africa Diabetic Retinopathy Market by Type
9.4.5.1.2 South Africa Diabetic Retinopathy Market by Treatment
9.4.5.2 Saudi Arabia Diabetic Retinopathy Market
9.4.5.2.1 Saudi Arabia Diabetic Retinopathy Market by Type
9.4.5.2.2 Saudi Arabia Diabetic Retinopathy Market by Treatment
9.4.5.3 U.A.E Diabetic Retinopathy Market
9.4.5.3.1 U.A.E Diabetic Retinopathy Market by Type
9.4.5.3.2 U.A.E Diabetic Retinopathy Market by Treatment
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diabetic Retinopathy Market Overview
9.5.2 South and Central America Diabetic Retinopathy Market Forecasts and Analysis
9.5.3 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.5.4 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.5.5 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diabetic Retinopathy Market
9.5.5.1.1 Brazil Diabetic Retinopathy Market by Type
9.5.5.1.2 Brazil Diabetic Retinopathy Market by Treatment
9.5.5.2 Argentina Diabetic Retinopathy Market
9.5.5.2.1 Argentina Diabetic Retinopathy Market by Type
9.5.5.2.2 Argentina Diabetic Retinopathy Market by Treatment
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DIABETIC RETINOPATHY MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALIMERA SCIENCE
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALLERGAN PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AMPIO PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAYER AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS INTERNATIONAL AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. REGENERON PHARMACEUTICALS INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VALEANT PHARMACEUTICAL
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
- Abbott Laboratories
- Alimera Science
- Allergan Plc
- Ampio Pharmaceuticals
- Bayer AG
- F. Hoffmann-LA Roche
- Novartis International AG
- PFIZER
- Regeneron Pharmaceuticals Inc
- Valeant Pharmaceutical
- Abbott Laboratories
- Alimera Science
- Allergan Plc
- Ampio Pharmaceuticals
- Bayer AG
- F. Hoffmann-LA Roche
- Novartis International AG
- PFIZER
- Regeneron Pharmaceuticals Inc
- Valeant Pharmaceutical